Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PharmKD
- Ownership
- Private
- Development stage
- Other
01
Overview
PharmKD was a specialized contract research organization (CRO) that focused on providing mass spectrometry-based pharmacokinetics (PK) and pharmacodynamics (PD) testing services. The company's core expertise lay in drug metabolite and biomarker profiling, supporting pharmaceutical and biotechnology clients in early-stage drug development. PharmKD was acquired in 2006 by Tandem Labs, a larger bioanalytical and immunoanalytical testing provider, to enhance its portfolio of specialized analytical services. Following the acquisition, its operations were integrated into Tandem Labs, which was subsequently acquired by LabCorp (Covance) in 2008.
- Industry
- Contract Research Organization
Beyond the preview
Go deeper on PharmKD.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PharmKD.